Customs (Prohibited Exports) Regulations (Amendment) (Cth)
REGULATIONS UNDER THE CUSTOMS ACT 1901-1974.*
I, THE GOVERNOR-GENERAL of
Australia, acting with the advice of the Executive Council, hereby make the
following Regulations under the
Dated this nineteenth day of December, 1974.
John R. Kerr
Governor-General.
By His Excellency’s Command,
(Sgd) LIONEL MURPHY
Minister of State for Customs and Excise.
Amendments of the Customs (Prohibited Exports) Regulation
(a) by omitting from sub-regulations (1), (2) and (3) the words “ the Collector ” (wherever occurring) and substituting the words “ the Director-General of Health ”;
(b) by omitting from sub-paragraph (1) (b) (i) the word “ and ”;
(c) by inserting in paragraph (1) (b) after sub-paragraph (ii) the following word and paragraph:—
“ ; and (iii) the exporter produces to the Collector the permission to export the drug granted by the Director-General of Health.”;
(d) by inserting in sub-regulation (2) after the words “ specified in ”, the words “ Parts I, II or III of ”;
(e) by omitting from sub-regulation (4) the word “ Part I ” and substituting the words “ Parts I, II or III ”; and
(f) by adding at the end thereof the following sub-regulations:—
“ (5) In this regulation and in regulations 10a, 10b and 10c—
‘ active principle ’ includes an active isomer or a mixture of isomers of a drug;
*
Notified in the
Statutory Rules 1958, No. 5, as amended by Statutory Rules 1959, No. 5; 1961, Nos. 16 and 112; 1963, Nos. 129 and 130; 1964, No. 144; 1965, No. 136; 1966, Nos. 70 and 75; 1967, Nos. 42, 59 and 123: 1968, Nos. 46, 83, 101, 153, 160 and 162; 1969, Nos. 11, 21, 22 and 219; 1970, Nos. 34, 68, 89, 106 and 121; 1972, No. 210; 1973, Nos. 4, 7, 39, 74, 102, 138, 218 and 248; and 1974, No. 46.
17017/73—Recommended retail price 10c 10/11.12.1974
‘ derivative ’ means any substance chemically derived from a drug or from which a drug may be regenerated and includes a salt;
‘ drug ’ means a narcotic drug or a psychotropic substance and includes a chemical or compound and a plant or a part of a plant, but does not include a preparation that is a narcotic preparation within the meaning of Schedule 3 to the Single Convention;
‘ narcotic drug ’ means a drug that is a drug for the purposes of the Single Convention;
‘ psychotropic substance ’ means any substance that is a psychotropic substance for the purposes of the Psychotropic Substances Convention and includes a preparation within the meaning of that Convention;
‘ Psychotropic Substances Convention ’ means the Convention on Psychotropic Substances that was adopted and opened for signature at Vienna on 21 February 1971;
‘ Single Convention ’ has the same meaning as the expression ‘ the Convention ’ has in the
Narcotic Drugs Act 1967-1973.
“ (6) For the purposes of this regulation, there shall be deemed to be specified in an item in the Eighth Schedule the name, in addition tothe name of the drug specified in that item, of each substance that is a drug by reason that it is—
(a) an active principle or derivative of the drug the name of which is specified in that item; or
(b) a derivative of an active principle, the name of which, is specified in that item.
“ (7) Where goods (including goods in the form of a preparation, mixture or solution) do not consist wholly of a drug but consist in part of, or contain, a drug, these goods shall be deemed to consist of that drug.”.
(a) by omitting from sub-regulation (1) the words “ the Collector ” and substituting the words “ the Director-General of Health ”;
(b) by omitting sub-regulation (2) and substituting the following sub-regulation:—
“ (2) The Director-General of Health shall grant an application for a licence under this regulation unless the grant would not be consistent with such of the requirements referred to in regulation 10c as are appropriate to the drug or drugs to which the application applies.”; and
(c) by omitting sub-regulation (4) and substituting the following sub-regulation:—
“ (4) The Director-General of Health may revoke a licence granted under this regulation if—
(a) the holder of the licence has failed to comply with a requirement to which the licence is, by regulation 10b, subject; or
(b) it would not be consistent with such of the requirements referred to in regulation 10c as are appropriate to the drugs to which the licence relates for the licence to continue in force. ”.
(a) by omitting from paragraph (b) the words “ the Collector ” and substituting the words “ the Director-General of Health ”;
(b) by omitting from paragraph (b) the word “ and ”;
(c) by omitting from paragraph (c) the words “ the Collector ” (wherever occurring) and substituting the words “ the Director-General of Health or an authorized officer or the Comptroller ”;
(d) by inserting after paragraph (c) the following paragraphs:—
“ (d) the person shall furnish to the Director-General of Health a return showing in respect of each week the records made by him in the book referred to in paragraph (a) ; and
“ (e) the person shall, when required to do so by the Director-General of Health or an authorized officer or the Comptroller, take any precautions necessary to ensure that there is no danger of loss or theft of drugs in his possession.”; and
(e) by adding at the end thereof the following sub-regulation:—
“ (2) In this regulation—
“ authorized officer ” means an officer of the Department of Health authorized in writing by the Director-General of Health to be an authorized officer for the purposes of this regulation.”.
“ 10c. The requirements approporiate to drugs that are, or are deemed to be, narcotic drugs are the requirements of the Single Convention and the requirements appropriate to drugs that are psychotropic substances are the requirements of the Psychotropic Substances Convention.
“ 10d. For the purposes of regulations 10, 10a, 10b and 10c, a drug that is not a narcotic drug or a psychotropic substance shall be deemed to be a substance specified in Schedule II to the Single Convention.
“ 10e. The Director-General of Health or the Comptroller, in exercising a power or performing a function under regulations 10, 10a or 10b shall have regard to such of the requirements referred to in regulation 10c as are appropriate and to no other matter.”.
EIGHTH SCHEDULE Regulations 10 and 10a
DRUGS THE EXPORTATION OF WHICH IS PROHIBITED UNLESS SPECIFIED CONDITIONS, RESTRICTIONS OR REQUIREMENTS ARE COMPLIED WITH
Part I
Item No. | Description of Drugs |
1 | Allylprodine |
2 | Alphameprodine |
3 | Alphaprodine |
4 | Anileridine |
5 | Benzethidine |
6 | Bezitramide |
7 | Clonitazene |
8 |
|
9 | Codeine |
10 | Desomorphine |
11 | Dextromoramide |
12 | Diampromide |
13 | Diethylthiambutene |
14 | Difenoxin |
15 | Dihydrocodeine |
16 | Dihydromorphine |
17 | Dimenoxadol |
18 | Dimepheptanol |
19 | Dimethylthiambutene |
20 | Dioxaphetyl butyrate |
21 | Diphenoxylate |
22 | Dipipanone |
23 | Drotebanol |
24 | Ecgonine |
25 | Ethylmethylthiambutene |
26 | Ethylmorphine |
27 | Etonitazene |
28 | Etorphine |
29 | Etoxeridine |
30 | Fentanyl |
31 | Furethidine |
32 | Heroin (diacetylmorphine) |
33 | Hydrocodone |
34 | Hydromorphinol |
35 | Hydromorphone |
36 | Hydroxypethidine |
37 | Isomethadone |
38 | Levophonacylmorphan |
39 | Levorphanol |
40 | Metazocine |
41 | Methadone |
42 | Methyldesorphine |
43 | Morpheridine |
44 |
|
45 | Noracymethadol |
46 | Norlevorphanol |
47 | Normethadone |
48 | Normorphine |
49 | Norpipanone |
50 |
|
| |
| |
|
Item No. | Description of Drugs |
51 | Oxycodone |
52 | Oxymorphone |
53 | Pentazocine |
54 | Pethidine |
55 | Pethidine-Intermediate C (1-methyl-4-Phenylpiperidine-4-carboxylic acid) |
56 | Phenadoxone |
57 | Phenampromide |
58 | Phenazocine |
59 | Phenomorphan |
60 | Phenoperidine |
61 | Pholcodine |
62 | Piminodine |
63 | Piritramide |
64 | Poppy straw |
65 | Proheptazine |
66 | Propiram |
67 | Thebaine, including plants and parts of plants of
the species |
68 | Trimeperidine |
69 |
|
Part II
Item No. | Description of Drugs |
1 | Amphetamine |
2 | Cannabis |
3 | Cannabis resin |
4 |
|
5 | DET (N,N-diethyltryptamine) |
6 | Dexamphetamine |
7 |
|
8 |
|
9 |
|
10 |
|
11 | Methamphetamine |
12 | Methylphenidate |
13 | Phencyclidine |
14 | Phenmetrazine |
15 |
|
16 | Psilocybin, including all fungi which contain psilocybin |
17 | STP, DOM (2-amino-1-(2,5-dimethoxy-4-methyl)-phenylpropane) |
18 |
|
Part III
Item No. | Description of Drugs |
1 | Amfecloral |
2 | Amfepramone (diethylpropion) |
3 |
|
4 | Chlorphentermine |
5 | Harmaline (4,9-dihydro-7-methoxy-1-methyl-(3H)pyrido(3,4-b)indole) |
6 | Harmine (7-methoxyharman) |
7 | Hydroxyamphetamine (4-(2-aminopropyl)phenyl) |
8 | Lysergic acid including the laevo isomer of lysergic acid |
9 | Alphamethyltryptamine (3-(2-aminopropyl)indole) |
10 | Phendimetrazine |
11 | Phentermine |
12 | Pipradrol |
13 | SPA, (levo-1-dimethylamine-1,2-diphenylethane) |
14 |
|
Part IV
Item No. | Description of Drugs |
1 |
|
2 | Ethchlorvynol (ethyl-2-chlorovinyl ethinyl carbinol) |
3 | Ethinamate |
4 | Glutethimide |
5 | Meprobamate |
6 | Methaqualone |
7 | Methyprylon |
(2) Notwithstanding the amendments of regulation 10a of the Customs (Prohibited Exports) Regulations made by regulation 2 of these Regulations, a licence granted under regulation 10a of those Regulations before the commencement of these Regulations and in force immediately before that commencement shall, on and after that commencement, be deemed to have been granted by the Director-General of Health and shall have the same force and effect as if the amendments made by regulation 2 of these Regulations had been in force immediately before the date on which the licence was granted.
Printed by Authority by the Government Printer of Australia
0
0
0